Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Automation in Biopharma Industry Market to reach USD 2779.8 million by the end of 2030

Global Automation in Biopharma Industry Market Size study & Forecast, by Technology (Automation Technology, Digitization Technology), by Application (Clinical Phase, Drug Discovery Phase, Production Phase), by Component (Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase), by Automation Technology (Supervisory Control and Data Acquisition (SCADA), Distributed Control Systems (DCS), Programmable Logic Controllers (PLC), Manufacturing Execution System (MES), Human-machine Interface (HMI), Advanced Process Control (APC), Others) by Digitization Technology (Internet of things (IoT), Artificial Intelligence (AI), Digital Twin Technology, Augmented Reality (AR) and Virtual Reality (VR), Predictive Analytics, Cloud Computing) and Regional Analysis, 2023-2030

Product Code: HLSHIT-12094289
Publish Date: 27-06-2023
Page: 200

Global Automation in Biopharma Industry Market is valued at approximately USD 1784.1 million in 2022 and is anticipated to grow with a healthy growth rate of more than 5.7% over the forecast period 2023-2030. Automation in the biopharma industry refers to the use of advanced technologies and software to automate various processes in the biopharmaceutical manufacturing and research sector. This includes automation of laboratory workflows, manufacturing processes, quality control, and data analysis. Automation in the biopharma industry aims to improve the efficiency, speed, and accuracy of these processes while also reducing errors and minimizing human intervention. The automation can involve the use of robots, sensors, artificial intelligence, and other advanced technologies to streamline the production process and increase productivity. The market growth is driven by key factors such as technological Advancements to Improve Product Safety and increasing need for machine flexibility.

Pharmaceutical companies stated they planned to adopt automated solutions more frequently, to the extent of 75%. Along with a lack of available labor, this is primarily driven by the trend toward injectables and more customized medications. Customized doses and products like pre-filled syringes put a strain on pharmaceutical production systems. In addition, there has been a surge in demand for telehealth and telemedicine after the Covid-19 epidemic began in 2020. Telemedicine primarily focuses on remote clinical services, but telehealth also covers remote non-clinical services. Since the pandemic, more individuals have adopted new working and living practices; as a result, this trend is anticipated to continue gaining speed. By 2026, it is predicted that the worldwide telemedicine industry would expand from $68.36 billion to $218.49 billion. Furthermore, EndeavorRx, which received FDA clearance in 2020, is the first and only video game therapy. The game, which requires a prescription, is meant to help youngsters with ADHD who are 8 to 12 years old increase their attention span. 73% of participants in clinical investigations stated their ability to pay attention had improved. Moreover, robotics is Valuable for Biopharma Operations, and research and Development Through Automation of Lab Processes are opportunities to enhance the market growth in the projected period. However, High Initial Investment Costs stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Automation in Biopharma Industry Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is dominating the market growth owing to the expansion of the pharmaceutical automation market in the N will be aided by the development of R&D facilities for the manufacturing of therapeutic drugs and expertise in novel drug formulation, as well as the region’s growing geriatric population and incidence of chronic illnesses.

Major market player included in this report are:
PerkinElmer, Inc.
AMETEK, Inc.
Autodesk, Inc.
Baumueller-Nuermont Corp
Emerson Electric Co.
Kawasaki Robotics
RheoSense Inc.
Rockwell Automation, Inc.
Sartorius Stedim Biotech SA
Siemens Healthineers

Recent Developments in the Market:

Ø February 2023, Siemens Healthineers and Unilabs agreed to a multi-year for more than USD 212.3 million. To upgrade its laboratory infrastructure and offer unmatched client service, Unilabs has invested in top-tier Siemens Healthineers technology and will purchase more than 400 laboratory analyzers.
Ø In September 2022, Cellaca® PLX Image Cytometry System was unveiled by PerkinElmer, Inc. It is a groundbreaking benchtop platform that enables researchers to evaluate numerous Critical Quality Attributes (CQAs) of cell samples in a single automated process, including cell identification, quality, and number.

Global Automation in Biopharma Industry Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Technology, Application, Component, Automation Technology, Digitization Technology, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:
Automation Technology
Digitization Technology
By Application:
Clinical Phase
Drug Discovery Phase
Production Phase
By Component:
Automation Hardware
Automation Software
Services Project Phase
Services Operation Phase
By Automation Technology:
Supervisory Control and Data Acquisition (SCADA)
Distributed Control Systems (DCS)
Programmable Logic Controllers (PLC)
Manufacturing Execution System (MES)
Human-machine Interface (HMI)
Advanced Process Control (APC)
Others
By Digitization Technology:
Internet of things (IoT)
Artificial Intelligence (AI)
Digital Twin Technology
Augmented Reality (AR) and Virtual Reality (VR)
Predictive Analytics
Cloud Computing

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Automation in Biopharma Industry Market, by Region, 2020-2030 (USD Million)
1.2.2. Automation in Biopharma Industry Market, by Technology, 2020-2030 (USD Million)
1.2.3. Automation in Biopharma Industry Market, by Application, 2020-2030 (USD Million)
1.2.4. Automation in Biopharma Industry Market, by Component, 2020-2030 (USD Million)
1.2.5. Automation in Biopharma Industry Market, by Automation Technology, 2020-2030 (USD Million)
1.2.6. Automation in Biopharma Industry Market, by Digitization Technology, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Automation in Biopharma Industry Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Automation in Biopharma Industry Market Dynamics
3.1. Automation in Biopharma Industry Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Technological Advancements to Improve Product Safety
3.1.1.2. Increasing Need for Machine Flexibility
3.1.2. Market Challenges
3.1.2.1. High Initial Investment Costs
3.1.3. Market Opportunities
3.1.3.1. Robotics is Valuable for Biopharma Operations
3.1.3.2. Research and Development Through Automation of Lab Processes
Chapter 4. Global Automation in Biopharma Industry Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Automation in Biopharma Industry Market, by Technology
5.1. Market Snapshot
5.2. Global Automation in Biopharma Industry Market by Technology, Performance – Potential Analysis
5.3. Global Automation in Biopharma Industry Market Estimates & Forecasts by Technology 2020-2030 (USD Million)
5.4. Automation in Biopharma Industry Market, Sub Segment Analysis
5.4.1. Automation Technology
5.4.2. Digitisation Technology
Chapter 6. Global Automation in Biopharma Industry Market, by Application
6.1. Market Snapshot
6.2. Global Automation in Biopharma Industry Market by Application, Performance – Potential Analysis
6.3. Global Automation in Biopharma Industry Market Estimates & Forecasts by Application 2020-2030 (USD Million)
6.4. Automation in Biopharma Industry Market, Sub Segment Analysis
6.4.1. Clinical Phase
6.4.2. Drug Discovery Phase
6.4.3. Production Phase
Chapter 7. Global Automation in Biopharma Industry Market, by Component
7.1. Market Snapshot
7.2. Global Automation in Biopharma Industry Market by Component, Performance – Potential Analysis
7.3. Global Automation in Biopharma Industry Market Estimates & Forecasts by Component 2020-2030 (USD Million)
7.4. Automation in Biopharma Industry Market, Sub Segment Analysis
7.4.1. Automation Hardware
7.4.2. Automation Software
7.4.3. Services Project Phase
7.4.4. Services Operation Phase
Chapter 8. Global Automation in Biopharma Industry Market, by Automation Technology
8.1. Market Snapshot
8.2. Global Automation in Biopharma Industry Market by Automation Technology, Performance – Potential Analysis
8.3. Global Automation in Biopharma Industry Market Estimates & Forecasts by Automation Technology 2020-2030 (USD Million)
8.4. Automation in Biopharma Industry Market, Sub Segment Analysis
8.4.1. Supervisory Control and Data Acquisition (SCADA)
8.4.2. Distributed Control Systems (DCS)
8.4.3. Programmable Logic Controllers (PLC)
8.4.4. Manufacturing Execution System (MES)
8.4.5. Human-machine Interface (HMI)
8.4.6. Advanced Process Control (APC)
8.4.7. Others
Chapter 9. Global Automation in Biopharma Industry Market, by Digitization Technology
9.1. Market Snapshot
9.2. Global Automation in Biopharma Industry Market by Digitization Technology, Performance – Potential Analysis
9.3. Global Automation in Biopharma Industry Market Estimates & Forecasts by Digitization Technology 2020-2030 (USD Million)
9.4. Automation in Biopharma Industry Market, Sub Segment Analysis
9.4.1. Internet of things (IoT)
9.4.2. Artificial Intelligence (AI)
9.4.3. Digital Twin Technology
9.4.4. Augmented Reality (AR) and Virtual Reality (VR)
9.4.5. Predictive Analytics
9.4.6. Cloud Computing
Chapter 10. Global Automation in Biopharma Industry Market, Regional Analysis
10.1. Top Leading Countries
10.2. Top Emerging Countries
10.3. Automation in Biopharma Industry Market, Regional Market Snapshot
10.4. North America Automation in Biopharma Industry Market
10.4.1. U.S. Automation in Biopharma Industry Market
10.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
10.4.1.2. Application breakdown estimates & forecasts, 2020-2030
10.4.1.3. Component breakdown estimates & forecasts, 2020-2030
10.4.1.4. Automation Technology breakdown estimates & forecasts, 2020-2030
10.4.1.5. Digitization Technology breakdown estimates & forecasts, 2020-2030
10.4.2. Canada Automation in Biopharma Industry Market
10.5. Europe Automation in Biopharma Industry Market Snapshot
10.5.1. U.K. Automation in Biopharma Industry Market
10.5.2. Germany Automation in Biopharma Industry Market
10.5.3. France Automation in Biopharma Industry Market
10.5.4. Spain Automation in Biopharma Industry Market
10.5.5. Italy Automation in Biopharma Industry Market
10.5.6. Rest of Europe Automation in Biopharma Industry Market
10.6. Asia-Pacific Automation in Biopharma Industry Market Snapshot
10.6.1. China Automation in Biopharma Industry Market
10.6.2. India Automation in Biopharma Industry Market
10.6.3. Japan Automation in Biopharma Industry Market
10.6.4. Australia Automation in Biopharma Industry Market
10.6.5. South Korea Automation in Biopharma Industry Market
10.6.6. Rest of Asia Pacific Automation in Biopharma Industry Market
10.7. Latin America Automation in Biopharma Industry Market Snapshot
10.7.1. Brazil Automation in Biopharma Industry Market
10.7.2. Mexico Automation in Biopharma Industry Market
10.8. Middle East & Africa Automation in Biopharma Industry Market
10.8.1. Saudi Arabia Automation in Biopharma Industry Market
10.8.2. South Africa Automation in Biopharma Industry Market
10.8.3. Rest of Middle East & Africa Automation in Biopharma Industry Market

Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.1.1. Company 1
11.1.2. Company 2
11.1.3. Company 3
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. PerkinElmer, Inc.
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Recent Developments
11.3.2. AMETEK, Inc.
11.3.3. Autodesk, Inc.
11.3.4. Baumueller-Nuermont Corp
11.3.5. Emerson Electric Co.
11.3.6. Kawasaki Robotics
11.3.7. RheoSense Inc.
11.3.8. Rockwell Automation, Inc.
11.3.9. Sartorius Stedim Biotech SA
11.3.10. Siemens Healthineers
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now